Weight loss

UK Weight-Loss Market Update: Oral GLP-1s Are Now a Provider Test

Weight-loss market update

The tablet market is no longer theoretical. Provider quality is the real comparison.

Wegovy Pill and Foundayo now sit beside injectable Wegovy, Mounjaro and orlistat on major UK provider pages. That makes price easier to scan, but it also makes clinical checks, dose advice and regulated supply more important.

14 Sepweekly snapshot £79lowest visible Foundayo intro 6 dosesorforglipron ladder
The week in brief

Boots Online Doctor still lists Wegovy tablets and Foundayo tablets from £99 in its weight-loss range, while Superdrug Online Doctor lists Wegovy Pill in stock from £99 and publishes a full Foundayo price ladder.

The wider story is that oral GLP-1s have moved into normal provider comparison. Visitors now need to compare active ingredient, dosing instructions, support, switching advice, future dose cost and whether the prescribing route is properly regulated.

In this round-up

Top stories

Oral GLP-1s are becoming a mainstream private-provider category

Boots Online Doctor lists Wegovy tablets from £99 and Foundayo tablets from £99 alongside injectable Wegovy, Mounjaro, orlistat and Xenical. Superdrug Online Doctor lists Wegovy Pill as in stock from £99, and its Foundayo page says Foundayo is now available in the UK through Superdrug Online Doctor.

That matters because the comparison is no longer just "injection or waitlist"; it is provider versus provider, dose ladder versus dose ladder, and support route versus support route. LloydsPharmacy Online Doctor shows how uneven the rollout can be, with its Foundayo explainer still describing the product as unavailable on that service.

Common tablet benchmarkFrom £99Boots and Superdrug
Highest listed Foundayo dose17.2mgmonthly escalation route
What this means for you

Do not treat the first price you see as the whole answer. Compare the dose you are likely to use, how the provider escalates treatment, what support is included and whether stock is confirmed inside the treatment flow.

The biggest tablet difference is not just price; it is how the medicine is taken

The MHRA approval for the Wegovy tablet sets out a daily semaglutide schedule starting at 1.5mg and moving through 4mg, 9mg and 25mg. The agency also notes that the tablet should be taken after fasting, with a wait before food or drink.

Foundayo is different. The MHRA's orforglipron announcement describes a once-daily tablet that can be taken at any time of day with no food or water restrictions, starting at 0.8mg and escalating through 2.5mg, 5.5mg, 9mg, 14.5mg and 17.2mg.

MedicineVisible comparison pointQuestion to ask
Wegovy PillDaily semaglutide tablet from £99 at major providers.Can you follow the fasting and timing rules consistently?
FoundayoDaily orforglipron tablet with six listed dose steps.What will the later dose cost and how will response be reviewed?
InjectablesWeekly options remain available, including Wegovy and Mounjaro.Is the provider comparing suitability, not just convenience?
Provider and safety checks

Regulated supply is still the non-negotiable part

The safety story is getting louder, not quieter.

The MHRA continues to warn that prescription-only weight-loss medicines should only be supplied after a proper assessment by a qualified healthcare professional. Its guidance also tells patients to use registered UK pharmacies or legitimate retailers and avoid unregulated websites or social media sellers.

That warning matters more as demand grows. If a page makes access sound instant, cheap and assessment-free, that is a risk signal rather than a bargain.

  • Check registration: look for the pharmacy and prescriber details, not just a logo.
  • Expect questions: BMI, medical history, medicines, side effects and photos may all be part of a legitimate assessment.
  • Separate news from availability: approval, pharmacy listing, dose availability and NHS access are different things.
  • Report problems: suspected side effects can be reported through the MHRA Yellow Card scheme.
What to watchThe better provider may be the one that slows the purchase down enough to check whether treatment is suitable.

What good provider pages should show this week

Practical comparison checks for oral and injectable treatments.

  • Price by dose: starter, escalation and maintenance costs should be easy to compare.
  • Clear instructions: daily tablets can have different timing, food and dose-escalation rules.
  • Clinical support: check how quickly you can message a clinician and what happens if side effects appear.
  • Stock honesty: a marketing page and checkout stock are not always the same signal.

Compare treatment providers before you choose

Review prices, support, treatment options and provider details side by side.

Medical disclaimer

This article is for general information only and is not medical advice. Prescription medicines should only be used after assessment by a qualified healthcare professional.

Check out these articles

Weight lossUK Treatment Promo and Pricing Round-Up: Week Commencing 14 September 2026

Current visible UK prices and offers across oral GLP-1s, weight loss, ED, blood tests, hair loss and TRT, with remi...

Read more
Weight lossUK Weight-Loss Market Update: Tablet Prices Are Now the Main Signal

This week in UK weight loss: oral GLP-1 pricing is clearer, Foundayo is appearing on major provider pages, and prov...

Read more
Weight lossUK Treatment Promo and Pricing Round-Up: Week Commencing 7 September 2026

Current visible UK prices and offers across oral GLP-1s, weight loss, ED, blood tests, hair loss and TRT, with remi...

Read more